These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31062086)

  • 1. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
    Cui G; Li Z; Ren J; Yuan A
    Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
    Cui G; Yuan A; Li Z; Goll R; Florholmen J
    Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
    Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
    Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of ST2 on regulatory T cells is associated with cancer associated fibroblast-derived IL-33 in laryngeal cancer.
    Zhao Y; Sun J; Liang Y; Jiang X; Tang X; Sun Y; Xu C; Wan G; Sun J; Pan C
    Pathol Res Pract; 2022 Sep; 237():154023. PubMed ID: 35908385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-33-expressing microvascular endothelial cells in human esophageal squamous cell carcinoma: Implications for pathological features and prognosis.
    Liu X; Li Z; Ren J; Cui G
    Microvasc Res; 2023 May; 147():104506. PubMed ID: 36792028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33 Effect on Quantitative Changes of CD4
    Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
    Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cancer cell-derived Foxp3 and tumor microenvironment in human tongue squamous cell carcinoma.
    Li K; Huang SH; Lao XM; Yang L; Liao GQ; Liang YJ
    Exp Cell Res; 2018 Sep; 370(2):643-652. PubMed ID: 30040923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of
    Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F
    Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma.
    Li W; An N; Wang M; Liu X; Mei Z
    Immun Inflamm Dis; 2022 Dec; 10(12):e746. PubMed ID: 36444617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.
    Zhou X; Su YX; Lao XM; Liang YJ; Liao GQ
    Oral Oncol; 2016 Feb; 53():27-35. PubMed ID: 26631955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher densities of Foxp3
    Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
    Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
    Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead box-P3
    Hussaini HM; Parachuru VPB; Seymour GJ; Rich AM
    Acta Histochem; 2017 Apr; 119(3):205-210. PubMed ID: 28174027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
    Son J; Cho JW; Park HJ; Moon J; Park S; Lee H; Lee J; Kim G; Park SM; Lira SA; Mckenzie AN; Kim HY; Choi CY; Lim YT; Park SY; Kim HR; Park SH; Shin EC; Lee I; Ha SJ
    Cancer Immunol Res; 2020 Nov; 8(11):1393-1406. PubMed ID: 32878747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
    Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
    Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
    Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
    Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.